Skip to content
Blog

>

Inside DNAnexus

Tri-Con 2018: Leveraging the Cloud to Power Multi-Omics Research

The Molecular Medicine Tri-Conference kicks off next week in downtown San Francisco. Bringing together over 3,700 attendees, Tri-Con is one of the world’s leading international events in the field of drug discovery, development, and diagnostics. The program is fully-loaded with presentations highlighting advancements in cancer research, big data, molecular diagnostics, precision medicine, rare disease, human microbiome, and more.

Please join us for our presentations during the Converged IT & The Cloud program and the Microbiome-Based Precision Medicine Symposium. Can’t make it to our talks? Email us to schedule a meeting with a member of our team.

Title: The Infrastructure Requirements for Geno-Pheno Analysis on a Massive Scale
Speaker: Omar Serang, Chief Cloud Officer, DNAnexus
Talk Details: Monday, February 12th at 3:55pm – Moscone South Convention Center
Program: Converged IT & The Cloud

Abstract:

Learn how Biopharmas are delivering on the promise of precision medicine by leveraging genomics in R&D. A comprehensive security and privacy framework is required to provide auditability, data immutability and versioning to reproduce research. Learn about the necessary infrastructure to scale geno-pheno analysis, while maintaining stringent security and compliance controls.

 

Title: Mosaic, a Cloud-Based Community Platform for the Acceleration of Translational Microbiome Science
Speaker: Michalis Hadjithomas, Microbiome Lead, DNAnexus
Talk Details: Thursday, February 15th at 12:15pm, Hilton San Francisco – Union Square
Program: Microbiome-Based Precision Medicine Symposium

Abstract:

Mosaic provides a collaborative space where researchers can implement and compare microbiome methods through community challenges. The “Strains” series of challenges encourages the improvement of strain-level performance of bioinformatic tools. “Standards” addresses experimental and computational sources of variability in metagenomic analyses to promote accurate and reproducible NGS-based microbiome profiling. Learn more and get started at http://mosaicbiome.com/.

 

Experience DNAnexus

Move Beyond Genomics

Most Recent

The Challenges Of Identifying Biomarkers And Molecular Patterns: Linking Clinical And Molecular Data

Navigating the intricate landscape of biomarker discovery to unlock new therapeutic avenues in ...

Unlocking New Frontiers in Neuroscience Drug Discovery with Omics and Biomarker Discovery Breakthroughs

Unlocking New Frontiers in Neuroscience Drug Discovery with Omics and Biomarker Discovery ...

The Future of Molecular Diagnostic Testing Will Depend on TREs